NCT04142476 Evaluation of the Impact of a Pharmaceutical Interview on the Adherence to Hormonotherapy in Women With Breast Cancer Status TERMINATED Phase NA
NCT04142060 Targeting the PAM50 Her2-Enriched Phenotype With Enzalutamide in Hormone Receptor-Positive/Her2-Negative Metastatic BC Status TERMINATED Phase PHASE2
NCT04141943 Improvement of Patient Experience and Healthcare Providers' Productivity Using Virtual Reality in the Field of Radiation Therapy Status UNKNOWN Phase NA
NCT04141449 A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04138719 Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer Status RECRUITING Phase PHASE2
NCT04138342 Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer Status UNKNOWN Phase PHASE1
NCT04137653 Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT Status RECRUITING Phase PHASE3
NCT04137640 Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy Status NOT_YET_RECRUITING Phase PHASE4
NCT04137406 Role of SIRT1 in Regulation of Epithelial-to-mesenchymal Transition in Breast Cancer Lymph Nodes Metastasis Status UNKNOWN Phase N/A
NCT04136782 Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer Status RECRUITING Phase PHASE4
NCT04136496 Evaluation of a Novel Axillary Lymph Node Ink Localization Technique: A Feasibility Study Status WITHDRAWN Phase NA
NCT04134780 Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response Status RECRUITING Phase N/A
NCT04134598 ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04132817 A Study of Multiple Immune and Disease Treatment Combinations in Participants With ER+HER2- Breast Cancer That Has Spread Status COMPLETED Phase PHASE1
NCT04131933 Evaluating Whether Integration of Prognostic and Predictive Algorithms Into Routine Clinical Practice Effect Whether Oncologists Order Multigene Assays in Patients With Early Stage Breast Cancer Status COMPLETED Phase N/A
NCT04131881 The Consistency of Drug Screening in Vitro and Neoadjuvant Chemotherapy Results in Breast Cancer Patients Status COMPLETED Phase N/A
NCT04131231 Safety and Effectiveness of MPCD Therapy on the Treatment of Malignant Pleural Effusion Status UNKNOWN Phase NA
NCT04130750 Comparison of pCR Rate After Neadjuvant Chemotherapy Guided by Result of in Vitro Cell Culture Drug Sensitivity or Physician's Choice Status UNKNOWN Phase EARLY_PHASE1
NCT04130152 Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy Status COMPLETED Phase EARLY_PHASE1